Association of Cyclin-Dependent Kinases 4 and 6 Inhibitors With Survival in Patients With Hormone Receptor–Positive Metastatic Breast Cancer: A Systematic Review and Meta-analysis

IMPORTANCE: One of the most recent treatment regimens used for hormone receptor (HR)–positive, ERBB2 (formerly HER2)–negative metastatic breast cancer is treatment with the cyclin-dependent kinases 4 and 6 (CDK4/6) inhibitors and endocrine therapy (ET). OBJECTIVE: To assess overall survival (OS), pr...

全面介紹

Na minha lista:
書目詳細資料
發表在:JAMA Netw Open
Main Authors: Li, Jinming, Huo, Xingfa, Zhao, Fuxing, Ren, Dengfeng, Ahmad, Raees, Yuan, Xinyue, Du, Feng, Zhao, Jiuda
格式: Artigo
語言:Inglês
出版: American Medical Association 2020
主題:
Original Investigation
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC8094425/
https://ncbi.nlm.nih.gov/pubmed/33048129
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamanetworkopen.2020.20312
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍